Description
RADIO-PHARMACEUTICAL SUPPLIES - RADIO-ISOTOPE SUPPLIES
First action · last action
2014-09-26 · 2015-09-01
Transactions
2
First transaction's obligation
$0
Base + all options value (sum of deltas)
$1,404,222
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
4
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-09-26+$0= $0
- Mod P000012015-09-01+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-09-26 | +$0 | $0 | RADIO-PHARMACEUTICAL SUPPLIES - RADIO-ISOTOPE SUPPLIES |
| Mod P00001· EXERCISE AN OPTION | 2015-09-01 | +$0 | $0 | RADIO-PHARMACEUTICAL SUPPLIES - RADIO-ISOTOPE SUPPLIES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI QJKJD5FKTNP3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426P0339 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $126,204 | FY2026 |
| 36C24426N0108 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $1,167,000 | FY2026 |
| 36C24425P0443 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $66,487 | FY2025 |
| 36C24425N0076 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $1,266,500 | FY2025 |
| 36C24424N0106 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $856,400 | FY2024 |
| 36C24423D0013 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
Other recipients under 6550 from 642-PHILADELPHIA (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24414P2554 | TRIPATH IMAGING, INC. | 642-PHILADELPHIA | $4,430 | FY2014 |
| VA24414P2552 | RESEARCH AND DIAGNOSTIC SYSTEMS, INC | 642-PHILADELPHIA | $4,985 | FY2014 |
| VA24414F2395 | ROCHE DIAGNOSTICS CORPORATION | 642-PHILADELPHIA | $11,189 | FY2014 |
| VA24414P1667 | LIFE TECHNOLOGIES CORPORATION | 642-PHILADELPHIA | $14,900 | FY2014 |
| VA24414P1464 | ATLANTA BIOLOGICALS INC | 642-PHILADELPHIA | $0 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA24415D0001_3600 · retrieved 2026-09-26.